The DOI matches its Crossref record; 171 of the 179 references it cites were found in a registry or an index.
Advances in the early diagnosis of hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers globally. In contrast to the declining death rates observed for all other common cancers such as breast, lung, and prostate cancers, the death rates for HCC continue to increase by ~2-3% per year because HCC is frequently diagnosed late and there is no curative therapy for an advanced HCC. The early diagnosis of HCC is truly a big challenge. Over the past years, the early diagnosis of HCC has relied on surveillance with ultrasonography (US) and serological assessments of alpha-fetoprotein (AFP). However, the specificity and sensitivity of US/AFP is not satisfactory enough to detect early onset HCC. Recent technological advancements offer hope for early HCC diagnosis. Herein, we review the progress made in HCC diagnostics, with a focus on emerging imaging techniques and biomarkers for early disease diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Without definitive tests, healthcare providers often depend on clinical judgment and broader testing approaches, sometimes resulting in diagnostic errors.”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [187]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“First, there is a lack of appropriate or specific diagnostic tests for certain conditions or diseases, especially in their early stages [185,186,187].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xu, W., Guo, B.-L., Han, Y.-G., Shi, L., & Ma, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2506-8 · Cited by 34
RetractedEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,135
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Omata, M., Cheng, A., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,219
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Llovet, J., Ducreux, M., Lencioni, R., Bisceglie, A. D., Galle, P., Dufour, J., Greten, T., Raymond, E., Roskams, T., de Baére, T., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,107
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Claudon, M., Dietrich, C. F., Choi, B. I., Cosgrove, D. O., Kudo, M., Nolsøe, C., Piscaglia, F., Wilson, S. R., Barr, R. G., Chammas, M. C., et al. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.09.002 · Cited by 969
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Capurro, M., Wanless, I. R., Sherman, M., DeBoer, G., Shi, W., Miyoshi, E., & Filmus, J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00689-9 · Cited by 918
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Xu, R., Wei, W., Krawczyk, M., Wang, W., Luo, H., Flagg, K., Yi, S., Shi, W. T., Quan, Q., Li, K., et al. (2017) · Nature Materials · doi:10.1038/nmat4997 · Cited by 867
Self-citationKudo, M., Izumi, N., Kokudo, N., Matsui, O., Sakamoto, M., Nakashima, O., Kojiro, M., Makuuchi, M., & for the HCC Expert Panel of Japan Society of Hepatology (2011) · Digestive Diseases · doi:10.1159/000327577 · Cited by 822
Singal, A. G., Pillai, A., & Tiro, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001624 · Cited by 817
Singal, A. G., Volk, M. L., Waljee, A. K., Salgia, R. J., HIGGINS, P., Rogers, M. A. M., & Marrero, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 816
Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., Xie, H., Chen, X., Shao, L., Zhang, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315084 · Cited by 782
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D. M., Llovet, J. M., Normolle, D. P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Trevisani, F., D'Intino, P. E., Morselli‐Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., Notariis, S. D., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 732
Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 661
Kudo, M., Matsui, O., Izumi, N., Iijima, H., Kadoya, M., Imai, Y., Okusaka, T., Miyayama, S., Tsuchiya, K., Ueshima, K., et al. (2014) · Liver Cancer · doi:10.1159/000343875 · Cited by 615
Biomarkers for the early diagnosis of hepatocellular carcinoma
Tsuchiya, N. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10573 · Cited by 571
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 538
MRI contrast agents: Classification and application (Review)
Xiao, Y., Paudel, R., Liu, J., Ma, C., Zhang, Z., & Zhou, S. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2744 · Cited by 511
The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine
Qi, P., & Du, X. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.160 · Cited by 509
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., & Nagataki, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282502 · Cited by 439
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
Sohn, W., Kim, J., Kang, S. H., Yang, S. R., Cho, J., Cho, H. C., Shim, S. G., & Paik, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.68 · Cited by 434
Gupta, S. N., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 423
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Zhou, F., Shang, W., Yu, X., & Tian, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21455 · Cited by 401
Shen, Q., Fan, J., Yang, X., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma
Chen, T., Xie, G., Wang, X., Fan, J., Qiu, Y., Zheng, X., Qi, X., Cao, Y., Su, M., Wang, X., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004945 · Cited by 364
Wald, C., Russo, M. W., Heimbach, J. K., Hussain, H. K., Pomfret, E. A., & Bruix, J. (2013) · Radiology · doi:10.1148/radiol.12121698 · Cited by 363
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M. J., Palmer, D. H., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 360
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
Li, D., Mallory, T., & Satomura, S. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00644-1 · Cited by 357
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
&NA; (1994) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199412000-00009 · Cited by 357
Kim, S. Y., An, J., Lim, Y.-S., Han, S., Lee, J.-Y., Byun, J. H., Won, H. J., Lee, S. J., Lee, H. C., & Lee, Y. S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3147 · Cited by 356
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017
Benson, A. B., D'Angelica, M. I., Abbott, D. E., Abrams, T. A., Alberts, S. R., Anaya, D. A., Are, C., Brown, D. B., Chang, D. T., Covey, A. M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0059 · Cited by 345
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 329
Pfeffer, S. R., Yang, C. H., & Pfeffer, L. M. (2015) · Drug Development Research · doi:10.1002/ddr.21257 · Cited by 325
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.042 · Cited by 324
Identification of Osteopontin as a Novel Marker for Early Hepatocellular Carcinoma
Shang, S., Plymoth, A., Ge, S., Feng, Z., Rosen, H. R., Sangrajrang, S., Hainaut, P. L., Marrero, J. A., & Beretta, L. (2011) · Hepatology · doi:10.1002/hep.24703 · Cited by 321
MR Elastography of Liver Tumors: Preliminary Results
Venkatesh, S. K., Yin, M., Glockner, J. F., Takahashi, N., Araoz, P. A., Talwalkar, J. A., & Ehman, R. L. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3123 · Cited by 312
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Li, W., Xie, L., He, X., Li, J., Tu, K., Wei, L., Wu, J., Guo, Y., Ma, X., Zhang, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23693 · Cited by 291
Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
Wang, H., Hou, L., Li, A., Duan, Y., Gao, H., & Song, X. (2014) · BioMed Research International · doi:10.1155/2014/864894 · Cited by 290
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics
Yang, N., Ekanem, N. R., Sakyi, C. A., & Ray, S. D. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.029 · Cited by 230
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., Wongjarupong, N., Ali, H. M., Ali, H. A., Hassan, F., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0281 · Cited by 230
Hanna, R. F., Miloushev, V. Z., Tang, A., Finklestone, L. A., Brejt, S. Z., Sandhu, R. S., Santillan, C., Wolfson, T. J., Gamst, A. C., & Sirlin, C. B. (2015) · Abdominal Radiology · doi:10.1007/s00261-015-0592-8 · Cited by 214
HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma
Li, J., Wang, X., Tang, J., Jiang, R., Zhang, W., Ji, J., & Sun, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430387 · Cited by 211
Li, L., Lei, Q., Zhang, S., Kong, L., & Qin, B. (2017) · Oncology Reports · doi:10.3892/or.2017.5946 · Cited by 205
Zhu, A. X., Gold, P. J., El-Khoueiry, A. B., Abrams, T. A., Morikawa, H., Ohishi, N., Ohtomo, T., & Philip, P. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2616 · Cited by 193
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
Zhang, Y., Wu, H., Shen, J., Ahsan, H., Tsai, W. Y., Yang, H., Wang, L., Chen, S., Chen, C., & Santella, R. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1900 · Cited by 192
Goossens, N., Singal, A. G., King, L. Y., Andersson, K. L., Fuchs, B. C., Besa, C., Taouli, B. A., Chung, R. T., & Hoshida, Y. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.26 · Cited by 183
Ten Things You Might Not Know about Iron Oxide Nanoparticles
Daldrup-Link, H. E. (2017) · Radiology · doi:10.1148/radiol.2017162759 · Cited by 181
El‐Serag, H. B., Kanwal, F., Davila, J. A., Kramer, J. R., & Richardson, P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.045 · Cited by 181
Bañales, J. M., Iñarrairaegui, M., Arbelaiz, A., Milkiewicz, P., Muntané, J., Muñoz‐Bellvís, L., Casta, A. L., González, L., Arretxe, E., Alonso, C., et al. (2018) · Hepatology · doi:10.1002/hep.30319 · Cited by 179
Kirk, G. D., Lesi, O. A., Mendy, M. E., Szymańska, K., Whittle, H. C., Goedert, J. J., Hainaut, P. L., & Montesano, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208732 · Cited by 179
Pocha, C., Dieperink, E. W., McMaken, K., Knott, A., THURAS, P. D., & Ho, S. B. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12370 · Cited by 171
A pathophysiological view of the long non-coding RNA world
Gesualdo, F. D., Capaccioli, S., & Lulli, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2770 · Cited by 169
Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancer
Zhang, B., & Yang, B. (1999) · Journal of Medical Screening · doi:10.1136/jms.6.2.108 · Cited by 163
Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer
Rao, C. V., Asch, A. S., & Yamada, H. Y. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw118 · Cited by 163
Gopal, P., Yopp, A. C., Waljee, A. K., Chiang, J., Nehra, M. S., Kandunoori, P., & Singal, A. G. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.053 · Cited by 158
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
Fornari, F., Ferracin, M., Treré, D., Milazzo, M., Marinelli, S., Galassi, M., Venerandi, L., Pollutri, D., Patrizi, C., Borghi, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141448 · Cited by 152
Wang, Y., Zhang, C., Zhang, P., Guo, G., Jiang, T., Zhao, X., Jiang, J., Huang, X., Tong, H., & Tian, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1390 · Cited by 148
Terahertz in-line digital holography of human hepatocellular carcinoma tissue
Lu, R., Latychevskaia, T., Chen, C., Wang, D., Yu, Z., Zhou, X., Li, Z., Huang, H., Wang, Y., & Zhou, Z. (2015) · Scientific Reports · doi:10.1038/srep08445 · Cited by 147
Mittal, S., Kanwal, F., Ying, J., Chung, R., Sada, Y. H., Temple, S., Davila, J. A., & El‐Serag, H. B. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.025 · Cited by 145
Besa, C., Lewis, S. C., Pandharipande, P. V., Chhatwal, J., Kamath, A., Cooper, N., Knight‐Greenfield, A., Babb, J. S., Boffetta, P., Padrón, N. A., et al. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0841-5 · Cited by 144
Xu, H., Chen, Y., Dong, X., & Wang, X. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0770 · Cited by 142
Tang, J., Jiang, R., Deng, L., Zhang, X., Wang, K., & Sun, B. (2015) · Oncotarget · doi:10.18632/oncotarget.2934 · Cited by 140
Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma
Kim, J., Ki, S. S., Lee, S. D., Han, C. J., Kim, Y. C., Park, S. H., Cho, S. Y., Hong, Y., Park, H. Y., Lee, M. J., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00679.x · Cited by 137
Epigenetic Changes in Solid and Hematopoietic Tumors
Toyota, M., & Issa, J. J. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.003 · Cited by 134
Zhang, C., Xi, Y., Quan, Q., Gao, Y., Wei, Q., & Han, S. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170727 · Cited by 133
Morgan, T. A., Maturen, K. E., Dahiya, N., Sun, M. R. M., & Kamaya, A. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1317-y · Cited by 127
Shao, Y., Zhu, B., Zheng, R., Zhao, X., Yin, P., Lu, X., Jiao, B., Xu, G., & Yao, Z. (2014) · Journal of Proteome Research · doi:10.1021/pr500973d · Cited by 123
Li, J., Han, X., Yu, X., Xu, Z., Yang, G., Liu, B., & Xiu, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0893-1 · Cited by 118
Huang, Z., Hu, Y., Hua, D., Wu, Y.-Y., Song, M., & Cheng, Z. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.08.004 · Cited by 116
Best, J., Bilgi, H., Heider, D., Schotten, C., Manka, P. P., Bedreli, S., Gorray, M., Ertle, J., van Grunsven, L. A., & Dechêne, A. (2016) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0042-119529 · Cited by 116
Huang, A., Zhang, X., Zhou, S., Cao, Y., Huang, X., Fan, J., Yang, X., & Zhou, J. (2016) · Journal of Cancer · doi:10.7150/jca.15823 · Cited by 113
Liao, W., Yang, H., Xu, H., Wang, Y., Ge, P., Ren, J., Xu, W., Lu, X., Sang, X., Zhong, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9629 · Cited by 112
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis
Shen, S. Y., Kong, J., Qiu, Y., Yang, X., Wang, W., & Yan, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28290 · Cited by 111
Self-citationAbbreviated MRI Protocols for the Abdomen
Canellas, R., Rosenkrantz, A. B., Taouli, B. A., Sala, E., Saini, S., Pedrosa, I., Wang, Z. J., & Sahani, D. V. (2019) · Radiographics · doi:10.1148/rg.2019180123 · Cited by 110
Role of Osteopontin in Liver Diseases
Wen, Y., Jeong, S., Xia, Q., & Kong, X. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16445 · Cited by 109
Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
Castilla-Lièvre, M.-A., Franco, D., Gervais, P., Kühnast, B., Agostini, H., Marthey, L., Désarnaud, S., & Helal, B.-O. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3241-0 · Cited by 108
Cheung, T. T., Ho, C. L., Lo, C. M., Chen, S., Chan, S. C., Chok, K., Fung, J., Chan, A. C. Y., Sharr, W. W., Yau, T. C. C., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107516 · Cited by 102
Qiu, L., Tang, Q., Li, G., & Chen, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.007 · Cited by 102
Systematic Review and Meta‐Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma
Huang, J., Liu, S., Ma, H., Yang, Y., Zhang, X., Sun, H., Zhang, X., Xu, J., & Wang, J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25135 · Cited by 101
New Serum Markers of Hepatocellular Carcinoma
Masuzaki, R., Karp, S. J., & Omata, M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.009 · Cited by 101
Terahertz Spectroscopy and Imaging: A Cutting-Edge Method for Diagnosing Digestive Cancers
Danciu, M., Alexa‐Stratulat, T., Ştefănescu, C., Dodi, G., Tamba, B.-I., Mihai, C. T., Stanciu, G. D., Luca, A., Spiridon, I. A., Ungureanu, L. B., et al. (2019) · Materials · doi:10.3390/ma12091519 · Cited by 100
Konishi, H., Ichikawa, D., Yamamoto, Y., Arita, T., Shoda, K., Hiramoto, H., Hamada, J., Itoh, H., Fujita, Y., Komatsu, S., et al. (2015) · Cancer Science · doi:10.1111/cas.12854 · Cited by 95
Xue, X., Zhao, Y., Wang, X., Qin, L., & Hu, R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27165 · Cited by 95
Hepatocellular Carcinoma: Perfusion Quantification With Dynamic Contrast-Enhanced MRI
Taouli, B. A., Johnson, R. S., Hajdu, C. H., Oei, M. T. H., Mérad, M., Yee, H. T., & Rusinek, H. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9798 · Cited by 94
Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases
Tian, L., Wang, Y., Xu, D., Gui, J., Jia, X., Tong, H., Wen, X., Dong, Z., & Tian, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25838 · Cited by 93
Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis
Schütte, K. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.139 · Cited by 92
Tillman, B. G., Gorman, J. D., Hru, J. M., Lee, M., King, M. C., Sirlin, C. B., & Marks, R. M. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.11.013 · Cited by 91
Ma, X., WANG, X., Yang, C., Wang, Z., Han, B., Wu, L., & Zhuang, L. (2016) · Anticancer Research · doi:10.21873/anticanres.11236 · Cited by 90
lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
Yanjun, C., & Dangjun, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.915100 · Cited by 88
Chen, L., Chu, F., Cao, Y., Shao, J., & Wang, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-3430-2 · Cited by 83
Zheng, Z., Pang, C., Yang, Y., Duan, Q., Zhang, J., & Liu, W. (2017) · Journal of International Medical Research · doi:10.1177/0300060517726441 · Cited by 83
Ladep, N. G., Dona, A. C., Lewis, M. R., Crossey, M. M. E., Lemoine, M., Okeke, E. N., Shimakawa, Y., Duguru, M. J., Njai, H. F., Fye, H. K. S., et al. (2014) · Hepatology · doi:10.1002/hep.27264 · Cited by 82
Jia, X., Liu, J., Gao, Y., Huang, Y. L., & Zhi, D. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.002 · Cited by 81
Wang, M., Devarajan, K., Singal, A. G., Marrero, J. A., Dai, J., Feng, Z., Rinaudo, J. A., Srivastava, S., Evans, A. A., Hann, H. W., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0186 · Cited by 81
Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma
Xie, D., Ren, Z., Zhou, J., Fan, J., & Gao, Q. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.11.01 · Cited by 79
Tin-filter Enhanced Dual-Energy-CT
Kaufmann, S., Sauter, A. W., Spira, D., Gatidis, S., Ketelsen, D., Heuschmid, M., Claussen, C. D., & Thomas, C. K. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.01.010 · Cited by 76
Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma
Makarem, M. A. A. E., Aleem, A. A., Ali, A. I., Saber, R. A., Shatat, M., Rahem, D. A., & Sayed, D. M. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31541-8 · Cited by 75
Witjes, C. D. M., van Aalten, S. M., Steyerberg, E. W., Borsboom, G., de Man, R. A., Verhoef, C. K., & IJzermans, J. N. M. (2012) · Hepatology International · doi:10.1007/s12072-012-9374-3 · Cited by 73
Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
Yeh, Y., Hu, T., Cho, P.-Y., Chen, H.-H., Yen, A. M.-F., Chen, S. L., Chiu, S. Y., Fann, J. C., Su, W., Fang, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26703 · Cited by 73
Hennedige, T. P., Hallinan, J. T. P. D., Leung, F. P., Teo, L., Iyer, S., Wang, G., Chang, S., Madhavan, K. K., Wee, A., & Venkatesh, S. K. (2015) · European Radiology · doi:10.1007/s00330-015-3835-8 · Cited by 71
Xu, W., Zhang, Z., Zhang, Y., Wang, Y., & Xu, L. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s90732 · Cited by 71
Caviglia, G. P., Abate, M. L., Petrini, E., Gaia, S., Rizzetto, M., & Smedile, A. (2015) · Hepatology Research · doi:10.1111/hepr.12544 · Cited by 70
Thurnherr, T., Mah, W.-C., Lei, Z., Yu, J. H., Rozen, S., & Lee, C. G. L. (2016) · Scientific Reports · doi:10.1038/srep20065 · Cited by 68
Ippolito, D., Sironi, S., Pozzi, M., Antolini, L., Invernizzi, F., Ratti, L., Leone, B. E., & Fazio, F. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.10.014 · Cited by 66
Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
Sun, B., Huang, Z. L., Wang, B., Yu, Y., Lin, S., Luo, L., Wang, Y., & Huang, Z. Y. X. (2017) · Medical Science Monitor · doi:10.12659/msm.899198 · Cited by 66
Chen, I., Ariizumi, S., Nakano, M., & Yamamoto, M. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0793-2 · Cited by 65
Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis
Yi, X., Yu, S., & Bao, Y. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.08.005 · Cited by 65
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma
Ge, T., Shen, Q., Wang, N., Zhang, Y., Ge, Z., Chu, W., Lv, X., Zhao, F., Zhao, W., Fan, J., et al. (2015) · Medical Oncology · doi:10.1007/s12032-014-0367-z · Cited by 64
RADIOIMMUNOASSAY OF ALPHA-FETOPROTEIN IN HUMAN PLASMA
Chayvialle, J., & Ganguli, P. C. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91676-0 · Cited by 64
Dai, M., Chen, X., Liu, X., Peng, Z., Meng, J., & Dai, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140067 · Cited by 64
Liao, W., Mao, Y., Ge, P., Yang, H., Xu, H., Lu, X., Sang, X., & Zhong, S. (2015) · Medicine · doi:10.1097/md.0000000000000722 · Cited by 62
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
Chen, H., Zhang, Y., Li, S., Li, N., Chen, Y., Zhang, B., Qu, C., Ding, H., Huang, J., & Dai, M. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167036 · Cited by 62
Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound
Zheng, S.-G. (2014) · World Journal of Radiology · doi:10.4329/wjr.v6.i1.7 · Cited by 61
Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation
Chae, W., & Bothwell, A. L. M. (2019) · Differentiation · doi:10.1016/j.diff.2019.05.003 · Cited by 60
Tanaka, H., Iijima, H., Nouso, K., Aoki, N., Iwai, T., Takashima, T., Sakai, Y., Aizawa, N., Iwata, K., Ikeda, N., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00936.x · Cited by 55
Elemeery, M. N., Badr, A. N., Mohamed, M. A., & Ghareeb, D. A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i21.3864 · Cited by 54
Fischer, M. A., Kartalis, N., Grigoriadis, A., Loizou, L., Stal, P. I., Leidner, B., Aspelin, P., & Brismar, T. B. (2015) · European Radiology · doi:10.1007/s00330-015-3732-1 · Cited by 54
Ning, S., Liu, H., Gao, B., Wei, W., Yang, A., Li, J., & Zhang, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.10606 · Cited by 54
Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis
Lim, K. S. (2013) · Clinical Radiology · doi:10.1016/j.crad.2013.07.022 · Cited by 52
Duarte‐Salles, T., Misra, S. K., Stępień, M., Plymoth, A., Muller, D. C., Overvad, K., Olsen, A., Tjønneland, A. M., Baglietto, L., Severi, G., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0434 · Cited by 52
Caviglia, G. P., Ribaldone, D. G., Abate, M. L., Ciancio, A., Pellicano, R., Smedile, A., & Saracco, G. M. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1459824 · Cited by 50
Burak, K. W., & Sherman, M. (2015) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2015/824263 · Cited by 49
Imaging of primary liver tumors with positron-emission tomography
Haug, A. R. (2017) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.17.02994-6 · Cited by 48
GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
Ba, M., Long, H., Tang, Y., & Cui, S.-Z. (2012) · PubMed Central · Cited by 46
Zuo, D., Chen, L., Liu, X., Wang, X., Xi, Q., Luo, Y., Zhang, N., & Guo, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4545-1 · Cited by 45
Sun, T., Tang, Y., Sun, D.-W., Bu, Q., & Li, P. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s186230 · Cited by 44
Circulating microRNAs for the diagnosis of hepatocellular carcinoma
Peng, C., Ye, Y., Wang, Z., Guan, L., Bao, S., Li, B., & Li, W. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.12.011 · Cited by 44
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
Zhao, M., Liu, Z., Dong, L., Zhou, H., Yang, S., Wu, W., & Lin, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168268 · Cited by 43
An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis
Zhang, Q., Han, Z., Ji, T., Zhao, M., Zhang, W., Li, P., Tang, L., & Gu, Y. (2018) · Biomaterials Science · doi:10.1039/c8bm01016a · Cited by 41
Shen, J., Li, X., Fan, L.-L., Zhou, X., Han, J., Jia, M.-K., Wu, L.-F., Zhang, X., & Chen, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126887 · Cited by 40
Ido, A. (2011) · Oncology Reports · doi:10.3892/or.2011.1425 · Cited by 38
Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis
Xia, Q., Li, Z., Zheng, J., Zhang, X., Yang, D., Ding, J., Yu, D., Li, Y., Shen, L., Yan, D., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27283 · Cited by 37
Zhang, Z. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32196 · Cited by 36
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients
Tahon, A. M., El-Ghanam, M., Zaky, S., Emran, T. M., Bersy, A. M., El‐Raey, F., Elsayed, A. Z., Kharsawy, A. M. E., & Johar, D. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0095-2 · Cited by 35
Li, X., Li, C., Wang, R., Ren, J., Yang, J., & Zhang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144247 · Cited by 34
Ma, X., Wang, S., Liu, S.-Y., Chen, K., Wu, Z., Li, D., Mi, Y.-T., Hu, L., Chen, Z., & Zhao, X. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3030 · Cited by 34
Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
Jain, S., Xie, L., Boldbaatar, B., Lin, S. Y., Hamilton, J. P., Meltzer, S. J., Chen, S., Hu, C., Block, T. M., Song, W., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12449 · Cited by 33
The emergence of long non-coding RNAs in hepatocellular carcinoma: an update
Peng, L., Yuan, X., Zhang, C., Peng, J., Zhang, Y., Pan, X., & Li, G. (2018) · Journal of Cancer · doi:10.7150/jca.24560 · Cited by 32
Yu, R., Ding, S., Tan, W., Tan, S., Tan, Z., Xiang, S., Zhou, Y., Mao, Q., & Deng, G. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.28806v2 · Cited by 31
Zhang, K., Song, P., Gao, J., Li, G., Zhao, X., & Zhang, S. (2014) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2014.01026 · Cited by 31
Li, Y.-W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4334 · Cited by 31
Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis
Chen, S., Zhang, Y., Wu, X., Zhang, C., & Li, G. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/8410195 · Cited by 30
Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma
Jiao, C., Cui, L., Piao, J., Qi, Y., & Yu, Z. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.199784 · Cited by 28
Jain, S., Wojdacz, T. K., & Su, Y. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.9 · Cited by 27
Fu, J., Li, Y., Li, Z., & Li, N. (2018) · Bioscience Reports · doi:10.1042/bsr20180044 · Cited by 26
Liu, J.-W., Zuo, X.-L., & Wang, S. (2015) · PubMed · Cited by 25
NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye
Zhang, C., Zhao, Y., Zhao, N., Tan, D., Zhang, H., Xue, C., Zhang, H., An, J., Shi, C., & Li, M. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/4979746 · Cited by 24
Developing slow-off dickkopf-1 aptamers for early-diagnosis of hepatocellular carcinoma
Zhou, Y., Li, W., Tseng, Y., Zhang, J., & Liu, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.014 · Cited by 23
Prognostication and response assessment in liver and pancreatic tumors: The new imaging
Robertis, R. D., Martini, P. T., Demozzi, E., Puntel, G., Ortolani, S., Cingarlini, S., Ruzzenente, A., Guglielmi, A., Tortora, G., Bassi, C., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i22.6794 · Cited by 23
Trung, N. T., Duong, D. C., Tong, H. V., Hiền, T. T. T., Hoan, P. Q., Bang, M. H., Binh, M. T., Ky, T. D., Tung, N. L., Thịnh, N. T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196081 · Cited by 20
Matsuda, M., Tsuda, T., Kido, T., Tanaka, H., Nishiyama, H., Itoh, T., Nakao, K., Hirooka, M., & Mochizuki, T. (2018) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000752 · Cited by 19
Feasibility of terahertz imaging for discrimination of human hepatocellular carcinoma
Duan, F., Wang, Y., Xu, D., Shi, J. M., Chen, L., Cui, L. G., Bai, Y., Xu, Y., Yuan, J., & Chang, C. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i2.153 · Cited by 19
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
Li, B., Li, B., Guo, T., Sun, Z., Li, X., Li, X., Wang, H., Chen, W., Chen, P., & Mao, Y. (2017) · BioMed Research International · doi:10.1155/2017/5358615 · Cited by 18
Gao, S., Zhang, X.-P., Cui, Y., Sun, Y., Tang, L., Li, X., Zhang, X.-Y., & Shan, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2014.08.15 · Cited by 15
Teng, L., Wang, K., Liu, Y., Ma, Y., Chen, W., & Bi, L. (2019) · BioMed Research International · doi:10.1155/2019/1742341 · Cited by 14
Li, W., Xiao, X. S., Li, X., Xu, Y., Ma, L., Guo, L., Yan, C., & Wu, Y. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/9169072 · Cited by 13
Zhao, J., Zhang, Z., Nie, D., Ma, H., Yuan, G., Su, S., Liu, S., Liu, S., & Tang, G. (2019) · Molecular Imaging · doi:10.1177/1536012118821032 · Cited by 11
Xiao, J., Long, F., Peng, T., Hu, L., Cai, H., Chen, R., & Chen, W. (2019) · PubMed · doi:10.26355/eurrev_201904_17692 · Cited by 10
Temperature-sensitive dna polymerase from rous sarcoma virus mutants
Baltimore, D., Verma, I. M., Drost, S. D., & Mason, W. S. (1974) · Cancer · doi:10.1002/1097-0142(197410)34:8+ · Cited by 9
Wang, K., Bai, Y., Chen, S., Huang, J., Yuan, J., Chen, W., Yao, P., Miao, X., Wang, Y., Liang, Y., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1481 · Cited by 8
Shun-YuGao, Xiao-PengZhang, YongCui, Ying-ShiSun, LeiTang, Xiao-TingLi, Xiao-YanZhang, & JunShan (2014) · Cited by 7
Pandya, P., & Kanwal, F. (2017) · Hepatology Communications · doi:10.1002/hep4.1087 · Cited by 6
Chen, C., Hsu, L.-S., Weng, J., Weng, H., Ye, Y., Hsu, S.-L., & Lin, W. (2018) · Medicine · doi:10.1097/md.0000000000013392 · Cited by 6
Cited by
Sorted by citations
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Safri, F., Nguyen, R., Zerehpooshnesfchi, S., George, J., & Qiao, L. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00764-w · Cited by 174
Wei, Y., Tang, X., Ren, Y., Yang, Y. S., Song, F., Fu, J., Liu, S., Yu, M., Chen, J., Wang, S., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00801-2 · Cited by 102
Tang, L., Wei, R., Chen, R., Fan, G., Zhou, J., Qi, Z., Wang, K., Wei, Q., Wei, X., & Xu, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.030 · Cited by 90
Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib
Yang, C., Lu, T., Liu, M., Yuan, X., Li, D., Zhang, J., Zhou, L., & Xu, M. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154668 · Cited by 90
Gajos-Michniewicz, A., & Czyz, M. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.050 · Cited by 89
Metadata
- Authors
- Wang, W., & Wei, C.
- Corresponding author
- Wei, Chao
- ORCID
- Venue
- Genes & Diseases
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 7
- Issue
- 3
- Pages
- 308-319
- ISSN
- 2352-3042 (ISSN-L)
- PMC
- PMC7452544
- OpenAlex
- W3003360914
- Cited by
- 492
- References
- 179
- Citations by year
- 2026: 56 · 2025: 107 · 2024: 126 · 2023: 108 · 2022: 74 · 2021: 19 · 2020: 2
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes & Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Keywords
- hepatocellular carcinoma, early diagnosis, alpha-fetoprotein, ultrasonography, cancer surveillance, imaging modalities, biomarkers, sensitivity and specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
